phosphoglycerate Mutase 1 (Brain) (PGAM1) (C-Term) Peptide
PGAM1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all PGAM1 products
- PGAM1 (phosphoglycerate Mutase 1 (Brain) (PGAM1))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- EEAIMELNLP TGIPIVYELD KNLKPIKPMQ FLGDEETVRK AMEAVAAQGK
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PGAM1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PGAM1 (phosphoglycerate Mutase 1 (Brain) (PGAM1))
- Background
-
Phosphoglyceric acid mutase (EC 2.7.5.3) is widely distributed in mammalian tissues where it catalyzes the reversible reaction of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate (2-PGA) in the glycolytic pathway.
Alias Symbols: PGAM-B, PGAMA
Protein Size: 254 - Molecular Weight
- 28 kDa
- Gene ID
- 5223
- NCBI Accession
- NM_002629, NP_002620
- UniProt
- P18669
-
You are here:
